Six-year-old William has severe food allergies and can not eat nuts, mustard, flaxseeds or sesame seeds.
His mum Stephanie is constantly weighing up the risks of him having an allergic reaction.
He had his first at the age of three, after drinking a smoothie at a coffee shop.
”We had a smoothie which he had a couple of times before,” she said.
”He said my tummy’s hurting. so we were like, don’t worry about it, we’ll get in the car, take you home and it was in the car he started becoming unresponsive.
“We got him home and he just vomited as soon as we walked in through the door. It was when we took off his clothes that we saw the hives and took him straight to hospital”
While allergies appear to be increasing, experts don’t completely understand why.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.